28795-81-5

Basic information

• Product Name: [1,4]Diazepan-6-ol
• Synonyms: [1,4]Diazepan-6-ol;[1,4]Diazepan-6-ol 2HBr;1H-1,4-Diazepin-6-ol, hexahydro-;6-METHOXY-1,4-DIAZEPANE 2HCL
• CAS NO: 28795-81-5
• Molecular Formula: C₅H₁₂N₂O
• Molecular Weight: 116.16
• Product Categories: pharmacetical
• Mol File: 28795-81-5.mol

Chemical Properties

• Boiling Point: 258.2°Cat760mmHg
• Flash Point: 144.4°C
• Appearance: /
• Density: 1.025g/cm³
• Vapor Pressure: 0.002mmHg at 25°C
• Refractive Index: 1.466
• CAS DataBase Reference: [1,4]Diazepan-6-ol(CAS DataBase Reference)
• NIST Chemistry Reference: [1,4]Diazepan-6-ol(28795-81-5)
• EPA Substance Registry System: [1,4]Diazepan-6-ol(28795-81-5)

Safety Data

• Hazardous Substances Data: 28795-81-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
[1,4]Diazepan-6-ol is used as a psychoactive drug for the treatment of various conditions, including anxiety, insomnia, and alcohol withdrawal symptoms. Its anxiolytic and sedative properties make it a popular choice for managing these issues. However, due to its potential for abuse and addiction, as well as the risk of dependence and withdrawal symptoms with long-term use, it is crucial to use this medication under the supervision of a healthcare professional and adhere to the prescribed dosage to avoid adverse effects and dependence.

InChI:InChI=1/C5H12N2O/c8-5-3-6-1-2-7-4-5/h5-8H,1-4H2

Upstream product

• 389062-84-4 1,4-dibenzyl-1,4-diazepan-6-ol 

Downstream Products

• 956317-40-1 tert-butyl 6-hydroxy-1,4-diazepane-1-carboxylate 
• 956317-41-2 tert-butyl 4-(2,6-dimethoxybenzoyl)-6-hydroxy-1,4-diazepane-1-carboxylate 
• 956317-43-4 tert-butyl 4-(2,6-dimethoxybenzoyl)-6-oxo-1,4-diazepane-1-carboxylate 
• 956317-42-3 1-(2,6-dimethoxybenzoyl)-1,4-diazepan-6-ol hydrochloride 

Relevant articles and documents

CXCR2 ANTAGONIST

A compound as a CXCR2 antagonist and an application thereof in preparing a drug as a CXCR2 antagonist. In particular, the present invention relates to a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof.

AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.